Bio-Rad Laboratories (BIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 912,973 | 649,938 | 204,524 | 161,764 | 223,607 |
| Marketable Securities | 118,636 | 94,876 | 38,950 | 61,977 | 264,473 |
| Receivables | 387,996 | 345,734 | 339,653 | 358,076 | 292,970 |
| Inventories | 398,100 | 351,206 | 375,616 | 321,015 | 253,045 |
| Income taxes - deferred | 48,021 | 43,102 | 41,408 | 36,450 | 35,862 |
| TOTAL | $1,975,346 | $1,562,674 | $1,093,941 | $1,028,974 | $1,129,777 |
| Non-Current Assets | |||||
| PPE Net | 333,617 | 302,417 | 300,732 | 271,561 | 189,627 |
| Intangibles | 567,862 | 532,405 | 550,410 | 538,743 | 164,097 |
| Other Non-Current Assets | 185,939 | 138,357 | 92,181 | 132,316 | 112,667 |
| TOTAL | $1,087,418 | $973,179 | $943,323 | $942,620 | $466,391 |
| Total Assets | $3,062,764 | $2,535,853 | $2,037,264 | $1,971,594 | $1,596,168 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 10,997 | 503 |
| Accounts payable and accrued liabilities | 113,440 | 92,988 | 117,982 | 96,470 | 83,411 |
| Accrued Expenses | 131,381 | 126,702 | 119,420 | 121,255 | 92,101 |
| Other current liabilities | 93,104 | 106,136 | 98,290 | 106,708 | 77,949 |
| TOTAL | $666,627 | $419,972 | $418,034 | $414,168 | $319,533 |
| Non-Current Liabilities | |||||
| Long Term Debt | 731,100 | 737,919 | 445,979 | 441,805 | 425,625 |
| Deferred Revenues | 20,642 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 63,335 | 51,310 | 51,287 | 91,415 | 23,960 |
| TOTAL | $855,618 | $836,668 | $548,590 | $585,736 | $457,097 |
| Total Liabilities | $1,522,245 | $1,256,640 | $966,624 | $999,904 | $776,630 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 27,880 | 27,547 | 27,320 | 26,968 | 26,614 |
| Common Shares | 3 | 3 | 3 | 3 | 3 |
| Retained earnings | 1,181,687 | 996,197 | 851,577 | 762,067 | 674,070 |
| Other shareholders' equity | 201,843 | 152,569 | 94,659 | 110,991 | 67,235 |
| TOTAL | $1,540,519 | $1,279,213 | $1,070,640 | $971,690 | $819,538 |
| Total Liabilities And Equity | $3,062,764 | $2,535,853 | $2,037,264 | $1,971,594 | $1,596,168 |